Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3
Mark J. Levis, Mehdi Hamadani, Brent R. Logan, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 15, pp. 1766-1775
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update
Yu Wang, Ying‐Jun Chang, Jing Chen, et al.
Cancer Letters (2024) Vol. 605, pp. 217264-217264
Closed Access | Times Cited: 16
Maintenance therapy with the FMS‐like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS‐like tyrosine kinase 3–internal tandem duplication acute myeloid leukemia: A phase 2 study
Emmanuel Gyan, Mark D. Minden, Kohmei Kubo, et al.
Cancer (2025) Vol. 131, Iss. 4
Open Access | Times Cited: 1
Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation
Clara Wienecke, Bennet Heida, Letizia Venturini, et al.
Blood (2024) Vol. 144, Iss. 3, pp. 296-307
Closed Access | Times Cited: 11
Current status and research directions in acute myeloid leukemia
Hagop M. Kantarjian, Gautam Borthakur, Naval Daver, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
Shai Shimony, Maximilian Stahl, Richard M. Stone
American Journal of Hematology (2025)
Open Access | Times Cited: 1
Challenges in Consensus Regarding the Treatment of Myeloid Malignancies
Hetty E. Carraway
(2025)
Closed Access
Теоретические и практические аспекты изучения фракций BAALC-экспрессирующих гемопоэтических стволовых клеток у больных острыми миелоидными лейкозами с мутациями в гене FLT3
Mamaev Nn, Mikhail M. Kanunnikov, Alena I. Shakirova, et al.
Clinical oncohematology (2025) Vol. 18, Iss. 1, pp. 73-85
Open Access
Advances and Challenges in Quizartinib‐Based FLT3 Inhibition for Acute Myeloid Leukemia: Mechanisms of Resistance and Prospective Combination Therapies
Antonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal Of Haematology (2025)
Open Access
Editorial: Molecular MRD testing in patients with acute myeloid leukemia
Amanda Blackmon, Michael R. Grunwald
Bone Marrow Transplantation (2025)
Open Access
The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.
Lori Muffly
The Hematologist (2025) Vol. 22, Iss. 1
Open Access
American Society of Transplantation and Cellular Therapy Series: #8- Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients
Abby Douglas, Frédéric Lamoth, T.M. John, et al.
Transplantation and Cellular Therapy (2025)
Closed Access
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT
Jaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
Bone Marrow Transplantation (2025)
Closed Access
SOHO State of the Art Updates and Next Questions Acute Myeloid Leukemia: Current Status and Next Questions
Vishrut Shah, Farhad Ravandi
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Margery Gang, Megan Othus, Roland B. Walter
Cells (2025) Vol. 14, Iss. 4, pp. 290-290
Open Access
Maintenance Therapy in AML: What Is the Future Potential?
Hannah Goulart, Andrew H. Wei, Tapan M. Kadia
American Journal of Hematology (2025) Vol. 100, Iss. S2, pp. 38-49
Open Access
Frontline Therapy of AML in the Fit and Younger Population—Incorporating Molecularly Targeted Agents
Keith W. Pratz, Harry P. Erba
American Journal of Hematology (2025) Vol. 100, Iss. S2, pp. 16-22
Open Access
Post-stem cell transplant maintenance for pediatric acute leukemias: insights from a Brazilian institution with a Latin American perspective
Carla Nolasco Monteiro Breviglieri, Roseane Vasconcelos Gouveia, Valéria Cortez Ginani, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Outcome of Patients with IDH-mutated AML following Allogeneic Stem Cell Transplantation – a Retrospective Analysis on behalf of the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRST
Thomas Schroeder, Sarah Flossdorf, Claudia Schuh, et al.
Transplantation and Cellular Therapy (2025)
Closed Access
Therapeutics of acute myeloid leukemia with central nervous system involvement
Edwin Uriel Suárez, Tamara Castaño-Bonilla, Rocío Salgado, et al.
Clinical Hematology International (2025) Vol. 7, Iss. 1
Open Access
Perspectives on Current Challenges and Emerging Approaches for the Management of CH, MDS, and AML From the 1st Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference
Hetty E. Carraway, Andrew M. Brunner, Catherine Lai, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
Jayastu Senapati, Tapan M. Kadia, Naval Daver, et al.
Cancer (2025) Vol. 131, Iss. 7
Closed Access
Editorial: Allogenic hematopoietic cell transplant in hematological malignancies: controversies and perspective
Salvatore Leotta, Sabrina Giammarco, Jacopo Mariotti
Frontiers in Oncology (2025) Vol. 15
Open Access
FLT3: A narrative review
Narender Kumar, Shrinidhi Nathany, Anusha Swaminathan, et al.
Cancer Research Statistics and Treatment (2025) Vol. 8, Iss. 1, pp. 66-74
Open Access
Ultrasensitive Detection of FLT3-ITD Mutations via Primer Competition Enhanced Mutant Accumulation
Ling Dai, Mengjun Deng, Kena Chen, et al.
Analytical Chemistry (2025)
Closed Access
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S. Hegde, et al.
Bone Marrow Transplantation (2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top